Literature DB >> 6236742

Low T8 antigen density on lymphocytes in active multiple sclerosis.

A T Reder, J P Antel, J J Oger, T A McFarland, M Rosenkoetter, B G Arnason.   

Abstract

The median fluorescence intensity of peripheral blood T8+ (T-suppressor/cytotoxic) cells in patients with active (relapsing or progressive) or stable multiple sclerosis (MS) and in control subjects was determined with a fluorescence-activated cell sorter using an indirect immunofluorescence assay. Median fluorescence intensity was significantly lower in patients with active MS than in controls. No differences in median fluorescence intensity were found between patients with stable MS and controls. Analysis of T8+ cells that had been modulated in vitro with OKT8 indicated that the resultant reduction in the median T8 antigen density per cell resulted in fewer T8+ cells being enumerated when the fluorescence-activated cell sorter was used than when a fluorescence microscope was used. Reduced median T8 antigen density on cells as found in active MS may contribute to the apparent underrepresentation of circulating T-suppressor cells in such patients and may be associated with reduced suppressor cell function.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6236742     DOI: 10.1002/ana.410160214

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  11 in total

1.  Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy.

Authors:  K Genç; D L Dona; A T Reder
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

2.  T-lymphocyte subsets modifications in multiple sclerosis: correlation with clinical disease activity.

Authors:  M Prencipe; E Salerni; C D'Aurizio; C Marini; D Adorno; A M Berghella; P Pellegrini; F Papola; C U Casciani
Journal:  Ital J Neurol Sci       Date:  1986-12

3.  Suppressor T cell changes in active multiple sclerosis: analysis with three different monoclonal antibodies.

Authors:  A J Thompson; J Brazil; E A Martin; M Hutchinson; C A Whelan; C Feighery
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-10       Impact factor: 10.154

4.  Cerebrospinal fluid lymphocyte subpopulations in multiple sclerosis.

Authors:  M G Marrosu; C Cianchetti; M G Ennas
Journal:  Ital J Neurol Sci       Date:  1986-02

5.  Effect of lymphocytapheresis plus cyclophosphamide on the course of a chronic progressive form of multiple sclerosis.

Authors:  S Ferla; G Meneghetti; S Spartà; M Belloni; G Ongaro
Journal:  Ital J Neurol Sci       Date:  1985-09

6.  Reduction of immunoglobulin G secretion in vitro following long term lymphoblastoid interferon (Wellferon) treatment in multiple sclerosis patients.

Authors:  M R O'Gorman; J Oger; L F Kastrukoff
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

7.  Peripheral blood T lymphocyte changes in multiple sclerosis: a marker of disease progression rather than of relapse?

Authors:  A J Thompson; J Brazil; C A Whelan; E A Martin; M Hutchinson; C Feighery
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-08       Impact factor: 10.154

Review 8.  Immunomodulatory activity of interferon-beta.

Authors:  Lloyd H Kasper; Anthony T Reder
Journal:  Ann Clin Transl Neurol       Date:  2014-07-23       Impact factor: 4.511

9.  Headache in relapse and remission phases of multiple sclerosis: A case-control study.

Authors:  Mansoureh Togha; Nahid Abbasi Khoshsirat; Abdorreza Naser Moghadasi; Faezeh Mousavinia; Mohammad Mozafari; Mohamadreza Neishaboury; Seyed Mahmood Mousavi
Journal:  Iran J Neurol       Date:  2016-01-05

Review 10.  Multiple sclerosis: neuroimmunologic puzzle.

Authors:  B P Barna
Journal:  Clin Lab Med       Date:  1986-03       Impact factor: 1.935

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.